InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (4 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
4
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by Flynn Daniel Lee, Directeur Scientifique. Officer active across 1 company, notably Deciphera Pharmaceuticals, Inc.. Aggregated, 7 filings have been logged. Breakdown: 0 buy · 4 sells. Total volume traded: €98k. Activity tracked since 15 December 2021. The latest transaction was filed on 16 June 2023 (Cession). Regulator: SEC (Form 4). All data is free.
Companies and markets linked to Flynn Daniel Lee
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations7 total
1,655 shares@ US$14.401820.0% of flowCommon StockSEC:0001209191-23-038753:0
16,488 shares0Common StockSEC:0001209191-23-010488:0
2,403 shares@ US$21.241343.4% of flowCommon StockSEC:0001209191-23-004001:0
1,768 shares@ US$10.7545.3% of flowCommon StockSEC:0001209191-22-038425:0
1,366 shares@ US$9.0527.4% of flowCommon StockSEC:0001209191-22-011360:0
20,500 shares0Common StockSEC:0001209191-22-004074:0
11,100 shares0Common StockSEC:0001209191-21-070227:0
7 of 7 declarations
About Flynn Daniel Lee
Daniel Lee Flynn is Chief Scientific Officer at Deciphera Pharmaceuticals, Inc. He is responsible for leading the company's research and development efforts. His scientific expertise is essential for the development of new treatments and for innovation within Deciphera Pharmaceuticals.
